Passage Bio, Inc. Share Price
PASGPassage Bio, Inc. Stock Performance
Open $4.89 | Prev. Close $4.68 | Circuit Range N/A |
Day Range $4.89 - $4.94 | Year Range $0.34 - $19.81 | Volume 210 |
Average Traded $4.92 |
Passage Bio, Inc. Share Price Chart
About Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Passage Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $4.89 | $4.94 | +0.00% |
29-Jun-26 | $4.89 | $4.94 | +5.56% |
26-Jun-26 | $4.72 | $4.68 | +5.64% |
25-Jun-26 | $4.66 | $4.43 | -25.48% |
24-Jun-26 | $5.92 | $5.95 | -2.54% |
23-Jun-26 | $5.80 | $6.10 | +7.77% |
22-Jun-26 | $5.74 | $5.66 | +4.04% |
FAQs on Passage Bio, Inc. Share Price
Can I buy Passage Bio, Inc. shares in India?
What is the share price of Passage Bio, Inc.?
What is the 5 year returns of Passage Bio, Inc.?
What are the high & low stock price of Passage Bio, Inc. today?
What is the 52-week high and low of Passage Bio, Inc. stock?